Boron Compounds
- Name
- Boron Compounds
- Accession Number
- DBCAT000461
- Description
Inorganic or organic compounds that contain boron as an integral part of the molecule.
- Drugs
Drug Drug Description Bortezomib A proteasome inhibitor used to treat multiple myeloma in patients who have not been successfully treated with at least two previous therapies. Phenylethane Boronic Acid Not Available 3-Nitrophenylboronic Acid Not Available AN0128 Investigated for use/treatment in acne, atopic dermatitis, pediatric indications, and psoriasis and psoriatic disorders. Flovagatran Investigated for use/treatment in thrombosis. Talabostat Investigated for use/treatment in lymphoma (non-hodgkin's), leukemia (lymphoid), lung cancer, melanoma, and pancreatic cancer. Boric acid No FDA- or EMA-approved therapeutic indications on its own. Delanzomib Delanzomib has been used in trials studying the treatment of Solid Tumors, Multiple Myeloma, and Lymphoma, Non-Hodgkin. Vaborbactam A beta lactamase inhibitor used to treat complicated urinary tract infections. Perboric acid In the industry, sodium perborate is used as a disinfectant. It is also part of the ingredients for detergents, bleach powders, and personal care formulations. In cosmetic products, perboric acid... Sodium borate No FDA- or EMA-approved therapeutic indications on its own. Borate ion Not Annotated Dutogliptin Dutogliptin has been investigated for the treatment of Diabetes Mellitus, Type II. Phenylboronic acid Not Available Tetrafluoroborate Tetrafluoroborate is under investigation in clinical trial NCT02907073 (Positron Emission Tomography (PET) Imaging Studies With NIS Reporter). INCB-057643 INCB-057643 is under investigation in clinical trial NCT02959437 (Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)). Taniborbactam Taniborbactam is under investigation in clinical trial NCT03840148 (Safety and Efficacy Study of Cefepime/vnrx-5133 in Patients With Complicated Urinary Tract Infections). Borocaptate Not Available - Drugs & Drug Targets